2016
DOI: 10.1007/s10847-016-0598-z
|View full text |Cite
|
Sign up to set email alerts
|

Inclusion complexes of fluconazole with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin in aqueous solution: preparation, characterization and a structural insight

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
31
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(37 citation statements)
references
References 30 publications
6
31
0
Order By: Relevance
“…A nuclear magnetic resonance (NMR) spectroscopic study was published in order to evaluate the complexation of fluconazole with β-CD, and the results confirmed the formation of an inclusion complex in aqueous solution [23,24]. Complexes of BFZ and miconazole prepared with different CDs by various methods such as kneading, co-evaporation, and physical mixing were characterized by Fourier transform infrared spectroscopy (FTIR) and DSC studies, and the effect of complexationon the dissolution rate of BFZ was studied [25,26].…”
Section: карактеризација на инклузиони комплекси меѓу бифоназол и разmentioning
confidence: 90%
“…A nuclear magnetic resonance (NMR) spectroscopic study was published in order to evaluate the complexation of fluconazole with β-CD, and the results confirmed the formation of an inclusion complex in aqueous solution [23,24]. Complexes of BFZ and miconazole prepared with different CDs by various methods such as kneading, co-evaporation, and physical mixing were characterized by Fourier transform infrared spectroscopy (FTIR) and DSC studies, and the effect of complexationon the dissolution rate of BFZ was studied [25,26].…”
Section: карактеризација на инклузиони комплекси меѓу бифоназол и разmentioning
confidence: 90%
“…The initial 3.3 % Flu sample mass loss in Figure a between 35 and 125 °C corresponds to the removal of the extraction solvent; the second mass loss (1.04 %), before Flu fusion begins, occurs between 125 and 242 °C, and can be attributed to total desolvation; at 242 °C, the crystallization of the compound begins, which melts and disintegrates at 375 °C. After that, the final weight loss is attributed to residues of the Flu precursors . The DSC curve for Flu in the same figure displayed an endothermic band (desolvation) at 90 °C; the process also presents two exothermic peaks at temperatures that correlate with the decomposition of Flu and the organic residues.…”
Section: Resultsmentioning
confidence: 86%
“…After that, the final weightl oss is attributed to residues of the Flu precursors. [52] The DSC curve for Flu in the same figure displayed an endothermicb and (desolvation) at 90 8C; the process also presents two exothermic peaks at temperatures that correlate with the decomposition of Flu and the organic residues.F igure 6b depicts the TGA/DSC of the SBA15 sample. Although the total loss of materiald uring the process was 10.6 %, consistent with the results of Ramanjaneya and Chennakesavulu, [53] the TGA line reveals three weight losses at temperatureso f3 5-200, 200-500, and 500-900 8C.…”
Section: Materials Characterizationmentioning
confidence: 73%
“…Low aqueous solubility often results in poor therapeutic outcome. Different solubility techniques were used to enhance its solubility, namely: solid dispersion (Sayeed et al, 2016), use of cyclodextrins (Yurtdas et al 2011;Li et al 2016;Ahad et al, 2011) and cocrystal formation with dicarboxylic acid (Kastelic et al, 2010). However, no literature reveals formation of FLC-ILs.…”
Section: * Corresponding Authormentioning
confidence: 99%